Department of the Army awards $1.15 million for small business research and development to Tessellated
The U.S. Army selected Tessellated to receive a Small Business Technology Transfer (STTR) Phase II contract to develop technologies that address military modernization challenges. The contract was awarded under the U.S. Army STTR program, which encourages small, high-tech, U.S.-based businesses (in partnership with major research institutions) to provide cutting-edge research and development solutions in response to critical defense needs. As with many agile technology companies, Tessellated is uniquely positioned to address the U.S. Army's modernization priorities.
Tessellated seeks to commercialize a high-strength polymer film discovered in the College of Engineering at the University of Notre Dame. This advanced material has a wide range of possible use cases and is application agnostic, including ballistic armor, thermal management and implementation in composite parts for aerospace and automotive applications.
Federal SBIR and STTR programs are known as "America's Seed Fund," enabling early-stage startups to develop critical technologies further and bring them to market. They are one of the largest sources of early-stage capital for technology commercialization in the United States. They meet federal research and development demand while increasing the potential for private-sector commercialization.
Central to the STTR program is the partnership between small businesses and nonprofit research institutions, catalyzing formal collaboration throughout Phase I and II development. According to SBIR.gov, STTR's most important role is to bridge the gap between basic science performance and the resulting innovations' commercialization.
In 2022 alone, Tessellated received three SBIR/STTR awards from the Department of Defense and the Department of Energy. The aggregate funding under these awards totals more than $500,000, with Notre Dame Research benefiting $167,000 in sub-awards as part of the STTR program.
According to Tessellated's CEO, Kevin Craig, "These non-dilutive awards coupled with local matching funds will allow Tessellated to continue to develop further innovations and chart a course toward scaled production. We will begin distributing material to our first customers and development partners in 2023."
For more information about Tessellated, visit tessellatedinc.com.
Originally published by ideacenter.nd.edu on March 21.
atLatest Research
- ‘A special challenge’: German studies scholar wins National Humanities Center fellowship for research on medieval womenFor CJ Jones, the joy of research is not the answers but the journey. And the next step on that journey is a fellowship with the National Humanities Center. …
- Notre Dame Lead Innovation Team partners with local WIC program to identify, prevent lead poisoning in childrenB.A.B.E. store “shoppers” now have something new to help their families: free lead screening kits offered by the University of Notre Dame’s Lead Innovation Team.
- Notre Dame Welcomes Ninth Cohort of Warrior-Scholars for Transformative Academic JourneyNOTRE DAME, IN – The University of Notre Dame recently concluded its ninth successful Warrior-Scholar Project (WSP) boot camp, hosting 34 dedicated Warrior-Scholars from June 21st to 28th. This intensive, week-long academic residency provided transitioning service members and veterans…
- Entrepreneurship and Empowerment in South Africa study abroad program celebrates 25 yearsThis year, the Entrepreneurship and Empowerment in South Africa (EESA) program marked its 25th year of operation. EESA is a six-week summer study abroad program that enables students to help historically…
- Vatican honors Martin and Carmel Naughton with papal awardCarmel…
- Brain tumor growth patterns may help inform patient care managementAssistant Professor Meenal Datta (University of Notre Dame/Wes Evard) A team of researchers from the University of Notre Dame, Harvard Medical School/Massachusetts General Hospital, and Boston University has developed a technique for measuring a brain tumor’s mechanical force and a new model to estimate how much brain tissue a patient has lost.